Endpoint
CD4+ T cell count
CAT:outcome/cd4-t-cell-countreported in cells/uL1 finding from 1 compound
What moved it
How to read these marks1 finding · 1 compound · by evidence strength
| Compound | Direction | Findings | Strongest evidence |
|---|---|---|---|
| L-arginine | up | 1 | Evidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers. |
Reported to move it
1 finding
L-arginine — increases
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“With regards to cellular immunity, the arginine group exhibited a substantial increase in the CD4+ T cell count (SMD = 1.03, 95% CI: 0.67-1.38) compared to the control group.”
Quoted verbatim from Arginine on immune function and post-operative obstructions in colorectal cancer patients: a meta-analysis.. - Study
- meta-analysis
- Population
- colorectal cancer patients undergoing surgery; overall pooled estimate
Arginine on immune function and post-operative obstructions in colorectal cancer patients: a meta-analysis.2024PMID:39223466Permalink
How it is measured
Absolute count of CD4-positive T lymphocytes per unit volume of peripheral blood by flow cytometry.
Measured, not recorded
- Subject
- cd4+ t cell count
- Measurements
- 1 measurement
- Recorded as a finding
- No
Show what was measured
CD4+ T cell count
increases, SMD = 1.03, 95% CI: 0.67-1.38, n = 589
Figure A shows that compared to the control group, the arginine group had significantly increased CD4+ T cell numbers (Z = 11.22, p < 0.001, SMD = 1.03, 95% CI: 0.67–1.38).
PMID:39223466 · one of two readings recorded this
Sources cited
1 paper
- Subject
- cd4+ t cell count
- Findings
- 1
- Papers
- 1